| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |